Immuneering (IMRX) EBITDA Margin (2020 - 2022)
Immuneering (IMRX) posted EBITDA Margin of -3055127.25% for Q4 2022, down 3049272.05 percentage points from -5855.20% a year earlier and down 3020961.65 percentage points from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) EBITDA Margin (2020 - 2022) Analysis & Trends
For FY2022, Immuneering's EBITDA Margin came in at -16238.30%, down 14611.32 percentage points from FY2021.
- In prior years, Immuneering's EBITDA Margin was -1626.98% in FY2021 (-889.02 pp) and -737.96% in FY2020.
- The Q4 2022 figure stands as the lowest quarterly EBITDA Margin in data going back to Q2 2020.
- On a year-over-year basis, EBITDA Margin has declined in each of the last seven quarters, with an average year-over-year change of -443638.05 percentage points over the last seven quarters.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -34165.60% (Q3 2022), -12268.90% (Q2 2022) and -7005.99% (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -3,055,127.25% |
| Sep 30, 2022 | -34,165.60% |
| Jun 30, 2022 | -12,268.90% |
| Mar 31, 2022 | -7,005.99% |
| Dec 31, 2021 | -5,855.20% |
| Sep 30, 2021 | -1,769.52% |
| Jun 30, 2021 | -1,209.19% |
| Mar 31, 2021 | -832.28% |
| Dec 31, 2020 | -876.44% |
| Sep 30, 2020 | -643.83% |
| Jun 30, 2020 | -748.85% |
API Access
Immuneering EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();